Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Frontiers in Pharmacology|March 25, 2022
Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial InfarctionAnna Campain, Carinna Hockham, Louisa Sukkar, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 14, 2023
Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classificationCarol Pollock, Juan Jose Garcia Sanchez, Juan-Jesus Carrero, et al.
European Journal of Heart Failure|January 23, 2025
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trialsSafia Chatur, Muthiah Vaduganathan, Robert A Fletcher, et al.
Nature Reviews. Nephrology|April 4, 2024
A new era in the science and care of kidney diseasesCarmine Zoccali, Francesca Mallamaci, Liz Lightstone, et al.
Clinical Kidney Journal|November 3, 2022
Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohortCarol Pollock, Glen James, Juan Jose Garcia Sanchez, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2025
Characteristics and cardio-renal outcomes in CKD patients receiving guideline-directed therapy: insights from DISCOVER CKDRoberto Pecoits-Filho, Eiichiro Kanda, Naoki Kashihara, et al.
Cardiovascular Diabetology|November 29, 2023
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trialAkihiko Koshino, Brendon L Neuen, Niels Jongs, et al.
Kidney International Reports|April 18, 2023
Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective CohortJuan Jose Garcia Sanchez, Glen James, Juan Jesus Carrero, et al.
Advances in Therapy|April 18, 2023
The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical TrialBartholomeus J A Willigers, Mario Ouwens, Andrew Briggs, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE TrialDavid M Charytan, Jie Yu, Meg J Jardine, et al.
Pageof 16